Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals

DOI DOI HANDLE HANDLE HANDLE ほか5件をすべて表示 一部だけ表示 研究データあり 参考文献1件 オープンアクセス

書誌事項

公開日
2022-06-13
DOI
  • 10.1038/s42003-022-03448-z
  • 10.5283/epub.52430
公開者
Springer Science and Business Media LLC

説明

<jats:title>Abstract</jats:title><jats:p>Reduced glomerular filtration rate (GFR) can progress to kidney failure. Risk factors include genetics and diabetes mellitus (DM), but little is known about their interaction. We conducted genome-wide association meta-analyses for estimated GFR based on serum creatinine (eGFR), separately for individuals with or without DM (n<jats:sub>DM</jats:sub> = 178,691, n<jats:sub>noDM</jats:sub> = 1,296,113). Our genome-wide searches identified (i) seven eGFR loci with significant DM/noDM-difference, (ii) four additional novel loci with suggestive difference and (iii) 28 further novel loci (including <jats:italic>CUBN</jats:italic>) by allowing for potential difference. GWAS on eGFR among DM individuals identified 2 known and 27 potentially responsible loci for diabetic kidney disease. Gene prioritization highlighted 18 genes that may inform reno-protective drug development. We highlight the existence of DM-only and noDM-only effects, which can inform about the target group, if respective genes are advanced as drug targets. Largely shared effects suggest that most drug interventions to alter eGFR should be effective in DM and noDM.</jats:p>

収録刊行物

参考文献 (1)*注記

もっと見る

キーワード

問題の指摘

ページトップへ